Ironwood Pharmaceuticals | Passivo Circulante



Current Liabilities Alterar Data
Acadia Pharmaceuticals USD 394.87M 50.92M 2024-12
Agios Pharmaceuticals USD 52.37M 28.79M 2025-03
Almirall EUR 274.01M 14.41M 2024-06
Alnylam Pharmaceuticals USD 1.08B 110.65M 2025-03
Amarin USD 201.55M 28.99M 2024-09
Ardelyx USD 77.83M 7.33M 2024-12
Astellas Pharma JPY 1.06T 90.95B 2025-03
AstraZeneca USD 29.13B 1.26B 2025-03
Charles River Laboratories USD 994.1M 18.12M 2024-12
Exact Sciences USD 502.46M 229.72M 2025-03
Halozyme Therapeutics USD 139.1M 30.28M 2024-12
Incyte USD 1.89B 244.96M 2025-03
Ironwood Pharmaceuticals USD 39.15M 10.24M 2024-12
MacroGenics USD 55.53M 3.78M 2024-12
Moderna USD 1.6B 602M 2025-03
Myriad Genetics USD 164.1M 9.8M 2024-12
Pacira USD 309.92M 3.52M 2024-12
PTC Therapeutics USD 580.98M 29.73M 2024-12
Sarepta Therapeutics USD 731.68M 32.2M 2024-12
Takeda JPY 2.1T 289.27B 2024-12
Ultragenyx Pharmaceutical USD 344.15M 59.14M 2024-12



Ironwood Pharmaceuticals Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.